Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms

SA Carratt, GL Kong, BM Curtiss… - Blood, The Journal …, 2022 - ashpublications.org
Colony stimulating factor 3 receptor (CSF3R) mutations lead to JAK pathway activation and
are the molecular hallmark of chronic neutrophilic leukemia (CNL). Approximately half of …

[PDF][PDF] Cell-type-specific responses to the microbiota across all tissues of the larval zebrafish

MS Massaquoi, GL Kong, D Chilin-Fuentes, JS Ngo… - Cell reports, 2023 - cell.com
Animal development proceeds in the presence of intimate microbial associations, but the
extent to which different host cells across the body respond to resident microbes remains to be …

PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia

BM Curtiss, J VanCampen, J Macaraeg, GL Kong… - Leukemia, 2022 - nature.com
Responses to kinase-inhibitor therapy in AML are frequently short-lived due to the rapid
development of resistance, limiting the clinical efficacy. Combination therapy may improve initial …

RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development

…, GL Kong, C Coblentz, Z Schonrock, L Maloney… - Leukemia, 2023 - nature.com
Acute myeloid leukemia (AML) is a deadly blood cancer characterized by an overproduction
of immature myeloid cells. AML has a high degree of genetic diversity, and the presence or …

PU. 1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia

BM Smith, J VanCampen, GL Kong, W Yashar… - BioRxiv, 2021 - biorxiv.org
Activating mutations in the KIT tyrosine receptor kinase confer an adverse prognosis for
patients with acute myeloid leukemia (AML). Successful treatment options are limited, as kinase …

[HTML][HTML] CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny

GL Kong, TT Nguyen, WK Rosales, AD Panikar… - BMC …, 2024 - Springer
Background The rapid advancement of new genomic sequencing technology has enabled
the development of multi-omic single-cell sequencing assays. These assays profile multiple …

[HTML][HTML] FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function

…, C Coblentz, RL Callahan, J VanCampen, GL Kong… - Blood, 2020 - Elsevier
Internal Tandem Duplication mutations of Fms Related Receptor Tyrosine Kinase 3 (FLT3),
known as FLT3-ITD mutations, are associated with poor prognosis in Acute Myeloid …

[HTML][HTML] Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment

…, C Huisman, KG Burfeind, KA Michaelis, G Kong… - Brain, behavior, and …, 2021 - Elsevier
Lipocalin 2 (LCN2) is a pleiotropic molecule that is induced in the central nervous system (CNS)
in several acute and chronic pathologies. The acute induction of LCN2 evolved as a …

[HTML][HTML] GoPeaks: histone modification peak calling for CUT&Tag

WM Yashar, G Kong, J VanCampen, BM Curtiss… - Genome biology, 2022 - Springer
Genome-wide mapping of histone modifications is critical to understanding transcriptional
regulation. CUT&Tag is a new method for profiling histone modifications, offering improved …

CITE-Viz: Replicating the Interactive Flow Cytometry Workflow in CITE-Seq

GL Kong, TT Nguyen, WK Rosales, AD Panikar… - bioRxiv, 2022 - biorxiv.org
The rapid advancement of new genomic sequencing technology has enabled the development
of multi-omic single-cell sequencing assays. These assays profile multiple modalities in …